.png)
Back
Rationale and Use of Botulinum Toxin Type A in the Management of Post Stroke Spasticity
Dr. Demetri Veliotes | Clinical
The mechanism for the development of spasticity and the rationale for botulinum toxin use, in the management of Post Stroke Spasticity
| Topic / Title of the Talk | Rationale and Use of Botulinum Toxin Type A in the Management of Post Stroke Spasticity |
| Field of Medicine | Neurology |
| Length of the Talk | 42 Mins |
| CPD Accreditation No. | MDB015/MPDP/070/678 |
| Category of the Talk | Overview |
| CPD Type | Clinical | Subscription CPD |
| Languages (Translations) & Subtitles | Not Translated |
| Speaker | Dr. Demetri Veliotes |
Talk Description
The mechanism for the development of spasticity and the rationale for botulinum toxin use, in the management of Post Stroke Spasticity.
Medtalkz webinar on Post Stroke Spasticity, May 2021.
See also Lecture by Meghan Noble on Post Stroke Spasticity, the challenges and therapeutic options
 new.png)